Climate Change Data

Biocon Limited

Climate Impact & Sustainability Data (2021, 2022-04 to 2023-03, 2023-04 to 2024-03, 2024, Q2 FY23)

Reporting Period: 2021

Environmental Metrics

Renewable Energy Share:53%

ESG Focus Areas

  • Patient Equity
  • People Equity
  • Social Equity
  • Environmental Equity
  • Stakeholder Equity

Environmental Achievements

  • 18% reduction in absolute Scope 1 and Scope 2 emissions (vs FY20 baseline)
  • 53% of electricity from green power
  • 100% of wastewater recycled and reused
  • ~5,500 tonnes of high-calorific waste sent for reuse as fuel
  • 400,000 liters of incremental water savings per day achieved through installation of a new ZLD effluent treatment plant
  • 17,092 tCO2 reduction from switchover to natural gas from furnace oil

Social Achievements

  • ~61,000 patient visits at Biocon Foundation-run eLAJ smart clinics
  • ~2,200 people screened for oral cancer using mHealth app
  • 700+ biotech graduates upskilled at Biocon Academy
  • Repurposed Itolizumab for treating COVID-19 patients (27,000+ lives impacted)
  • 185,000 RT-PCR Tests for COVID-19 conducted
  • 3.1 million patients reached globally through biosimilars
  • 96.8 million in CSR spending

Governance Achievements

  • Robust governance policies (Code of Conduct, Whistle-blower policy, etc.)
  • Five Board committees
  • Strong Quality Management System aligned with GxP
  • Appointed a team of 120 Local Ethics Officers (LEOs) to ensure compliance to the Code of Conduct
  • Zero tolerance for child labor

Climate Goals & Targets

Medium-term Goals:
  • 50:50 gender ratio by 2030

Environmental Challenges

  • Inequity in global healthcare access
  • COVID-19 pandemic impact
Mitigation Strategies
  • Partnerships with UNAIDS, CHAI, etc.
  • ‘Mission 10 cents’ insulin initiative
  • Repurposing Itolizumab for COVID-19 treatment
  • Proactive COVID-19 safety measures for employees

Supply Chain Management

Responsible Procurement
  • Local sourcing
  • Responsible raw material sourcing

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI

Certifications: ISO 14001:2015 & ISO 45001:2018

Sustainable Products & Innovation

  • Reusable insulin pens

Awards & Recognition

  • ISPE Facility of the Year Award (Honorable Mention)
  • Avtar Women’s lists of ‘Best Companies for Mothers’ and ‘Most Inclusive Companies’
  • UN Women recognition for promoting gender diversity
  • DivHERsity Awards for ‘Most Innovative Practices’

Reporting Period: 2022-04 to 2023-03

Environmental Metrics

Total Carbon Emissions:99337.94 tCO2e/year
Scope 1 Emissions:55835.85 tCO2e/year
Scope 2 Emissions:43502.09 tCO2e/year
Scope 3 Emissions:111518 tCO2e/year
Renewable Energy Share:60.4%
Total Energy Consumption:447532.33 MWh/year
Carbon Intensity:1.2 tCO2e/INR million revenue

ESG Focus Areas

  • Climate Change
  • Diversity & Inclusion
  • Access to Medicines
  • Sustainable Operations
  • Responsible Supply Chain

Environmental Achievements

  • Increased green power usage to 60.4% of total power requirement.
  • Reduced CO2 emissions by 120,950 tons through renewable energy and fuel switching.
  • Commissioned India’s largest biomass boiler for process steam, reducing CO2 emissions.
  • Achieved 75% renewable energy at major sites in Q4 FY23.

Social Achievements

  • Launched several employee well-being programs.
  • Secured USD 1.2 billion Sustainability Linked Loan (SLL) tied to ESG targets.

Governance Achievements

  • Established robust sustainability governance framework and strategy.
  • Board-level oversight of climate-related issues.
  • ESG linked performance in employee scorecards (5% weightage).

Climate Goals & Targets

Long-term Goals:
  • Net-zero emissions
Medium-term Goals:
  • Achieve 90% renewable energy for Bengaluru sites by 2025.
  • Reduce Scope 1 and 2 emissions by 20% by 2032.
  • Reduce Scope 3 emissions by 10% by 2032.
Short-term Goals:
  • Reduce water consumption.
  • Increase renewable energy to 90% at Bengaluru sites by 2024.

Environmental Challenges

  • Water stress impacting operations.
  • Risk of flooding at manufacturing sites.
  • Reputational risks from stakeholder concerns on climate action.
  • Unsuccessful investment in new technologies.
  • Enhanced emissions-reporting obligations.
  • Heat stress impacting employee health and operations.
Mitigation Strategies
  • Implementing water conservation measures (recycling, reuse, storage).
  • Developing business continuity plans for extreme weather events.
  • Transparent reporting on climate strategy and measures.
  • Robust quality and manufacturing systems for low-carbon transitions.
  • Integrating climate risks into enterprise risk management.
  • Employee benefits and wellness programs, engineering controls.

Supply Chain Management

Supplier Audits: 28 GMP audits in FY23

Responsible Procurement
  • Supplier Code of Conduct
  • ESG criteria for vendor evaluation
  • Sustainability requirements

Climate-Related Risks & Opportunities

Physical Risks
  • Water stress
  • Flooding
  • Heat stress
Transition Risks
  • Technological change
  • Market shifts
  • Regulatory changes
Opportunities
  • Resource efficiency
  • Market demand for low-carbon products
  • Renewable energy

Reporting Standards

Frameworks Used: TCFD, GRI, BRSR, UNGC

Third-party Assurance: DNV

UN Sustainable Development Goals

  • Goal 7 (Affordable and Clean Energy)
  • Goal 13 (Climate Action)

Initiatives contribute to these goals through renewable energy adoption, emissions reduction, and community projects.

Sustainable Products & Innovation

  • Low-carbon APIs identified through LCA

Awards & Recognition

  • S&P Global Sustainability Yearbook
  • BW Businessworld Annual Rating
  • Golden Peacock Award for Sustainability
  • UNWEP India award
  • Best Sustainability Practices in Procurement award

Reporting Period: 2023-04 to 2024-03

Environmental Metrics

Total Carbon Emissions:125,922 tCO2e/year
Scope 1 Emissions:23,273 tCO2e/year
Scope 2 Emissions:25,307 tCO2e/year
Scope 3 Emissions:77,342 tCO2e/year
Renewable Energy Share:75%
Total Energy Consumption:276,992 MWh/year
Water Consumption:1.10 million m3/year (withdrawal)
Waste Generated:28,846 tons/year
Carbon Intensity:1.60 tCO2 eq/Revenue in million ₹ (BL), 0.97 tCO2 eq/Revenue in million ₹ (BBL)

ESG Focus Areas

  • Product quality
  • Research and Development
  • Access & affordability
  • Environmental performance
  • Future ready workplace
  • Digitization
  • Supply chain sustainability
  • Community engagement
  • Inclusion and diversity
  • Governance
  • Ethical sales and marketing
  • Climate

Environmental Achievements

  • Recycled 78% of water (up from 60% the previous year)
  • Recycled 83% of waste generated
  • 58% of total power consumed sourced from renewable sources
  • 18,765 tCO2e GHG emissions (Scope 1 and Scope 2) offset
  • 155,414 metric tons of CO2 emissions avoided due to energy saving initiatives
  • 100% of wastewater generated (India Operations) recycled and reused

Social Achievements

  • Achieved 17.6% women in workforce at Biocon Limited
  • Biocon Biologics reached out to 1,100+ patients through donation programs in low- and middle-income countries
  • Donation of approximately 12,500 insulin glargine injection pens and 1,000 glargine vials
  • Collaboration with Action4Diabetes (A4D) to supply insulin at subsidized costs

Governance Achievements

  • Implemented an anti-corruption and anti-bribery policy
  • Established ‘Corporate Social Responsibility and Environmental, Social and Governance Committee’

Climate Goals & Targets

Medium-term Goals:
  • 25% reduction in Scope 1 and Scope 2 emissions by FY29 from baseline year FY20
  • 25% freshwater consumption reduction by FY29 from baseline year FY23
  • 100% circular waste by FY29 from baseline year FY23, includes zero waste to landfill by FY29
  • To plant 15,000 trees by FY29
Short-term Goals:
  • At least 20% women in the workforce by 2025 at Biocon Limited

Environmental Challenges

  • Product quality risks (recalls, safety, regulatory compliance)
  • Environmental performance risks (regulatory compliance, climate change)
  • Future ready workplace risks (safe workplace, talent retention)
  • Supply chain sustainability risks (disruptions, dependencies)
  • Governance risks (ethics, compliance)
Mitigation Strategies
  • Stringent quality control measures, automated processes, digital initiatives, improved quality culture, continuous training
  • Sustainable practices (renewable energy, water usage, waste management), climate risk considerations in business strategy
  • Robust safety procedures, continuous improvement initiatives, employee well-being programs, talent mobility, succession planning
  • Integrated approach, cost-effective logistics, supplier audits, Supplier Code of Conduct, alternative vendors, inventory management
  • Global best practices in corporate governance and risk management, independent compliance tracking

Supply Chain Management

Supplier Audits: 11 critical vendors/suppliers assessed at BL, 127 critical vendors assessed at BBL

Responsible Procurement
  • Supplier Code of Conduct
  • Biocon Biologics’ Business Partner Code of Conduct
  • Periodic audits on business sustainability parameters

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
Transition Risks
  • Regulatory pressures
Opportunities
  • Resource conservation
  • Energy efficiency

Reporting Standards

Frameworks Used: GRI Standards 2021, UNGC, S&P Global Dow Jones Sustainability Indices (DJSI), BRSR (Core) framework by SEBI, AA1000AS v3

Certifications: ISO 14001, ISO 45001, ISO 27001:2013, GMP

Third-party Assurance: Emergent Ventures India Pvt. Ltd.

Awards & Recognition

  • S&P Global’s Sustainability Yearbook for 2024
  • EcoVadis Silver Medal

Reporting Period: 2024

Environmental Metrics

Total Carbon Emissions:61,601 MT CO2e reduction from energy conservation
Renewable Energy Share:82%
Water Consumption:78,225 KL saved
Waste Generated:2,255 MT recycled

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Reduced energy usage by 3%
  • Achieved 82% power from renewable sources
  • Saved 78,225 Kiloliters of water through recycling and reuse
  • Recycled 96% of total hazardous and non-hazardous waste
  • Achieved zero waste to landfill at all facilities

Social Achievements

  • Contributed to funding of IISc Post Graduate medical school and hospital
  • Contributed to the new Bangalore metro
  • Extended Synquizitive science quiz to 7,500 students
  • Revamped employee induction process
  • Achieved 88% employee engagement score

Governance Achievements

  • Committed to Science-Based Targets (SBTi) for greenhouse gas emissions reduction
  • US FDA approval for API manufacturing facility in Mangalore
  • Received ISO: 50001 certification for energy conservation
  • Recognized as one of ‘India’s Best Managed Companies’ by Deloitte India

Climate Goals & Targets

Medium-term Goals:
  • 67% of suppliers representing Scope 3 emissions to commit to SBTi targets
Short-term Goals:
  • Reduce Scope 1 and 2 greenhouse gas emissions by 50% by 2033

Environmental Challenges

  • Challenging financing environment in US biotech impacting Discovery Services revenue and margins
  • Price sensitivity from clients and price aggression from competitors
  • Slowdown in outsourcing due to normalization of biotechnology funding levels
Mitigation Strategies
  • Expanded operations in Hyderabad with integrated chemistry and biology services
  • Commissioned automated compound management facility
  • Acquired new capabilities such as oligonucleotide synthesis
  • Focus on digitization and automation to drive efficiency
  • Leveraging customer-centric mindset to build partnerships
  • Investment in robust leadership, exceptional talent and cutting-edge technology

Supply Chain Management

Responsible Procurement
  • ESG assessment of critical suppliers
  • Upskilling sessions for suppliers
  • Commitment to decarbonization aligned with SBTi goals

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: SBTi

Certifications: ISO 45001, ISO 50001

Awards & Recognition

  • India’s Best Managed Companies (Deloitte)
  • Best Overall Sustainable Performance Award
  • Silver Award in Environmental Excellence
  • Best Energy Efficient Case Study (CII)
  • Supply Chain Champion in Pharmaceutical Sector (ISCM)

Reporting Period: Q2 FY23

Environmental Metrics

Total Carbon Emissions:118K tCO2e (offset)
Renewable Energy Share:58%

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • 58% electricity came from green power
  • 100% waste water recycled & reused
  • 118K tCO2 GHG offset

Social Achievements

  • Top 5 among global pharma & biotech employer since 2012
  • Published Human Rights Policy
  • Recognized by UN Women for efforts to promote diversity
  • Rs. 11 Crore in CSR Spend
  • 13% increase in women in workforce
  • 5.3M patients reached through biosimilars

Governance Achievements

  • Board Committees, policies for global governance
  • Published 1st Tax Policy & Transparency Report, Supplier Code of Conduct
  • Published 1st GRI aligned ESG & BRSR Report for FY22

Climate Goals & Targets

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI

UN Sustainable Development Goals

  • UN Sustainable Development Goals (SDGs)

Biocon has drawn up a manifesto to deliver on its commitment to universal healthcare.